nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00506	0.0051	CcSEcCtD
Levobunolol—Conjunctivitis—Erlotinib—kidney cancer	0.00496	0.005	CcSEcCtD
Levobunolol—Erectile dysfunction—Sorafenib—kidney cancer	0.00475	0.00478	CcSEcCtD
Levobunolol—Chest pain—Temsirolimus—kidney cancer	0.00473	0.00477	CcSEcCtD
Levobunolol—Syncope—Pazopanib—kidney cancer	0.0047	0.00474	CcSEcCtD
Levobunolol—Cerebrovascular accident—Gemcitabine—kidney cancer	0.0047	0.00474	CcSEcCtD
Levobunolol—Cardiac arrest—Vincristine—kidney cancer	0.00461	0.00465	CcSEcCtD
Levobunolol—Loss of consciousness—Pazopanib—kidney cancer	0.0046	0.00464	CcSEcCtD
Levobunolol—Ataxia—Vincristine—kidney cancer	0.00456	0.0046	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00455	0.00459	CcSEcCtD
Levobunolol—Chest pain—Pazopanib—kidney cancer	0.00446	0.0045	CcSEcCtD
Levobunolol—Depression—Sunitinib—kidney cancer	0.00441	0.00444	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.00438	0.00442	CcSEcCtD
Levobunolol—Erythema multiforme—Erlotinib—kidney cancer	0.00433	0.00437	CcSEcCtD
Levobunolol—Keratitis—Doxorubicin—kidney cancer	0.00433	0.00437	CcSEcCtD
Levobunolol—Cardiac failure congestive—Paclitaxel—kidney cancer	0.00425	0.00428	CcSEcCtD
Levobunolol—Nasal congestion—Paclitaxel—kidney cancer	0.00423	0.00427	CcSEcCtD
Levobunolol—Alopecia—Vinblastine—kidney cancer	0.00421	0.00425	CcSEcCtD
Levobunolol—Shock—Pazopanib—kidney cancer	0.00421	0.00424	CcSEcCtD
Levobunolol—Alopecia—Everolimus—kidney cancer	0.0042	0.00423	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00415	0.00418	CcSEcCtD
Levobunolol—Arrhythmia—Erlotinib—kidney cancer	0.0041	0.00413	CcSEcCtD
Levobunolol—Visual disturbance—Paclitaxel—kidney cancer	0.00407	0.0041	CcSEcCtD
Levobunolol—Alopecia—Erlotinib—kidney cancer	0.00405	0.00408	CcSEcCtD
Levobunolol—Dyspnoea—Temsirolimus—kidney cancer	0.00405	0.00408	CcSEcCtD
Levobunolol—Bradycardia—Sunitinib—kidney cancer	0.00404	0.00407	CcSEcCtD
Levobunolol—Hypoglycaemia—Paclitaxel—kidney cancer	0.00395	0.00398	CcSEcCtD
Levobunolol—Lethargy—Paclitaxel—kidney cancer	0.00393	0.00396	CcSEcCtD
Levobunolol—Cerebrovascular accident—Paclitaxel—kidney cancer	0.00393	0.00396	CcSEcCtD
Levobunolol—Bronchospasm—Gemcitabine—kidney cancer	0.00391	0.00395	CcSEcCtD
Levobunolol—Erythema multiforme—Sorafenib—kidney cancer	0.0039	0.00393	CcSEcCtD
Levobunolol—Pain—Temsirolimus—kidney cancer	0.00388	0.00391	CcSEcCtD
Levobunolol—Erectile dysfunction—Vincristine—kidney cancer	0.00386	0.00389	CcSEcCtD
Levobunolol—Paraesthesia—Pazopanib—kidney cancer	0.00384	0.00387	CcSEcCtD
Levobunolol—Dyspnoea—Pazopanib—kidney cancer	0.00381	0.00384	CcSEcCtD
Levobunolol—Erythema multiforme—Sunitinib—kidney cancer	0.00375	0.00378	CcSEcCtD
Levobunolol—Depression—Vincristine—kidney cancer	0.00373	0.00376	CcSEcCtD
Levobunolol—Syncope—Everolimus—kidney cancer	0.00371	0.00374	CcSEcCtD
Levobunolol—Arrhythmia—Sorafenib—kidney cancer	0.00368	0.00371	CcSEcCtD
Levobunolol—Cardiac arrest—Paclitaxel—kidney cancer	0.00366	0.00369	CcSEcCtD
Levobunolol—Pain—Pazopanib—kidney cancer	0.00366	0.00369	CcSEcCtD
Levobunolol—Palpitations—Everolimus—kidney cancer	0.00365	0.00369	CcSEcCtD
Levobunolol—Alopecia—Sorafenib—kidney cancer	0.00364	0.00367	CcSEcCtD
Levobunolol—Diabetes mellitus—Capecitabine—kidney cancer	0.00364	0.00367	CcSEcCtD
Levobunolol—Loss of consciousness—Everolimus—kidney cancer	0.00363	0.00367	CcSEcCtD
Levobunolol—Ataxia—Paclitaxel—kidney cancer	0.00362	0.00365	CcSEcCtD
Levobunolol—Syncope—Erlotinib—kidney cancer	0.00358	0.00361	CcSEcCtD
Levobunolol—Erythema multiforme—Dactinomycin—kidney cancer	0.00355	0.00358	CcSEcCtD
Levobunolol—Arrhythmia—Sunitinib—kidney cancer	0.00354	0.00357	CcSEcCtD
Levobunolol—Chest pain—Everolimus—kidney cancer	0.00352	0.00355	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00352	0.00355	CcSEcCtD
Levobunolol—Loss of consciousness—Erlotinib—kidney cancer	0.00351	0.00354	CcSEcCtD
Levobunolol—Alopecia—Sunitinib—kidney cancer	0.00351	0.00354	CcSEcCtD
Levobunolol—Stinging—Doxorubicin—kidney cancer	0.00347	0.00349	CcSEcCtD
Levobunolol—Chest pain—Erlotinib—kidney cancer	0.0034	0.00343	CcSEcCtD
Levobunolol—Hypersensitivity—Temsirolimus—kidney cancer	0.00334	0.00337	CcSEcCtD
Levobunolol—Shock—Everolimus—kidney cancer	0.00332	0.00335	CcSEcCtD
Levobunolol—Alopecia—Dactinomycin—kidney cancer	0.00332	0.00335	CcSEcCtD
Levobunolol—Asthenia—Temsirolimus—kidney cancer	0.00326	0.00328	CcSEcCtD
Levobunolol—Lethargy—Capecitabine—kidney cancer	0.00323	0.00325	CcSEcCtD
Levobunolol—Cerebrovascular accident—Capecitabine—kidney cancer	0.00323	0.00325	CcSEcCtD
Levobunolol—Syncope—Sorafenib—kidney cancer	0.00322	0.00325	CcSEcCtD
Levobunolol—Pruritus—Temsirolimus—kidney cancer	0.00321	0.00324	CcSEcCtD
Levobunolol—Shock—Erlotinib—kidney cancer	0.0032	0.00323	CcSEcCtD
Levobunolol—Timolol—ABCB1—kidney cancer	0.00319	0.388	CrCbGaD
Levobunolol—Diplopia—Capecitabine—kidney cancer	0.00316	0.00319	CcSEcCtD
Levobunolol—Loss of consciousness—Sorafenib—kidney cancer	0.00316	0.00318	CcSEcCtD
Levobunolol—Hypotension—Everolimus—kidney cancer	0.00315	0.00318	CcSEcCtD
Levobunolol—Diarrhoea—Temsirolimus—kidney cancer	0.0031	0.00313	CcSEcCtD
Levobunolol—Asthenia—Pazopanib—kidney cancer	0.00307	0.00309	CcSEcCtD
Levobunolol—Paraesthesia—Vinblastine—kidney cancer	0.00304	0.00307	CcSEcCtD
Levobunolol—Paraesthesia—Everolimus—kidney cancer	0.00303	0.00306	CcSEcCtD
Levobunolol—Pruritus—Pazopanib—kidney cancer	0.00302	0.00305	CcSEcCtD
Levobunolol—Erythema multiforme—Gemcitabine—kidney cancer	0.00301	0.00304	CcSEcCtD
Levobunolol—Dyspnoea—Everolimus—kidney cancer	0.00301	0.00303	CcSEcCtD
Levobunolol—Cardiac arrest—Capecitabine—kidney cancer	0.00301	0.00303	CcSEcCtD
Levobunolol—Dizziness—Temsirolimus—kidney cancer	0.003	0.00303	CcSEcCtD
Levobunolol—Ataxia—Capecitabine—kidney cancer	0.00297	0.003	CcSEcCtD
Levobunolol—Alopecia—Vincristine—kidney cancer	0.00297	0.00299	CcSEcCtD
Levobunolol—Depression—Paclitaxel—kidney cancer	0.00296	0.00299	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00294	0.00297	CcSEcCtD
Levobunolol—Chest pain—Sunitinib—kidney cancer	0.00294	0.00297	CcSEcCtD
Levobunolol—Diarrhoea—Pazopanib—kidney cancer	0.00292	0.00295	CcSEcCtD
Levobunolol—Dyspnoea—Erlotinib—kidney cancer	0.0029	0.00293	CcSEcCtD
Levobunolol—Pain—Vinblastine—kidney cancer	0.0029	0.00292	CcSEcCtD
Levobunolol—Atrioventricular block—Doxorubicin—kidney cancer	0.0029	0.00292	CcSEcCtD
Levobunolol—Conjunctivitis—Paclitaxel—kidney cancer	0.00289	0.00291	CcSEcCtD
Levobunolol—Pain—Everolimus—kidney cancer	0.00289	0.00291	CcSEcCtD
Levobunolol—Shock—Sorafenib—kidney cancer	0.00288	0.00291	CcSEcCtD
Levobunolol—Arrhythmia—Gemcitabine—kidney cancer	0.00284	0.00287	CcSEcCtD
Levobunolol—Headache—Temsirolimus—kidney cancer	0.00284	0.00287	CcSEcCtD
Levobunolol—Dizziness—Pazopanib—kidney cancer	0.00283	0.00285	CcSEcCtD
Levobunolol—Alopecia—Gemcitabine—kidney cancer	0.00281	0.00284	CcSEcCtD
Levobunolol—Feeling abnormal—Vinblastine—kidney cancer	0.00279	0.00282	CcSEcCtD
Levobunolol—Pain—Erlotinib—kidney cancer	0.00278	0.00281	CcSEcCtD
Levobunolol—Feeling abnormal—Everolimus—kidney cancer	0.00278	0.0028	CcSEcCtD
Levobunolol—Shock—Sunitinib—kidney cancer	0.00277	0.0028	CcSEcCtD
Levobunolol—Bradycardia—Paclitaxel—kidney cancer	0.00271	0.00274	CcSEcCtD
Levobunolol—Nausea—Temsirolimus—kidney cancer	0.0027	0.00272	CcSEcCtD
Levobunolol—Bronchospasm—Capecitabine—kidney cancer	0.00269	0.00271	CcSEcCtD
Levobunolol—Headache—Pazopanib—kidney cancer	0.00268	0.0027	CcSEcCtD
Levobunolol—Dyspnoea—Sorafenib—kidney cancer	0.00261	0.00263	CcSEcCtD
Levobunolol—Visual impairment—Paclitaxel—kidney cancer	0.00257	0.00259	CcSEcCtD
Levobunolol—Nausea—Pazopanib—kidney cancer	0.00254	0.00256	CcSEcCtD
Levobunolol—Nadolol—ABCB1—kidney cancer	0.00253	0.308	CrCbGaD
Levobunolol—Paraesthesia—Sunitinib—kidney cancer	0.00253	0.00255	CcSEcCtD
Levobunolol—Erythema multiforme—Paclitaxel—kidney cancer	0.00252	0.00254	CcSEcCtD
Levobunolol—Dyspnoea—Sunitinib—kidney cancer	0.00251	0.00253	CcSEcCtD
Levobunolol—Pain—Sorafenib—kidney cancer	0.00251	0.00253	CcSEcCtD
Levobunolol—Hypersensitivity—Vinblastine—kidney cancer	0.0025	0.00252	CcSEcCtD
Levobunolol—Hypersensitivity—Everolimus—kidney cancer	0.00249	0.00251	CcSEcCtD
Levobunolol—Asthenia—Vinblastine—kidney cancer	0.00243	0.00245	CcSEcCtD
Levobunolol—Depression—Capecitabine—kidney cancer	0.00243	0.00245	CcSEcCtD
Levobunolol—Asthenia—Everolimus—kidney cancer	0.00242	0.00244	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00242	0.00244	CcSEcCtD
Levobunolol—Pain—Sunitinib—kidney cancer	0.00241	0.00243	CcSEcCtD
Levobunolol—Pruritus—Everolimus—kidney cancer	0.00239	0.00241	CcSEcCtD
Levobunolol—Arrhythmia—Paclitaxel—kidney cancer	0.00238	0.0024	CcSEcCtD
Levobunolol—Conjunctivitis—Capecitabine—kidney cancer	0.00237	0.00239	CcSEcCtD
Levobunolol—Chest pain—Gemcitabine—kidney cancer	0.00236	0.00238	CcSEcCtD
Levobunolol—Alopecia—Paclitaxel—kidney cancer	0.00236	0.00238	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—kidney cancer	0.00234	0.00236	CcSEcCtD
Levobunolol—Asthenia—Erlotinib—kidney cancer	0.00234	0.00236	CcSEcCtD
Levobunolol—Urticaria—Sorafenib—kidney cancer	0.00233	0.00235	CcSEcCtD
Levobunolol—Diarrhoea—Vinblastine—kidney cancer	0.00232	0.00234	CcSEcCtD
Levobunolol—Diarrhoea—Everolimus—kidney cancer	0.00231	0.00233	CcSEcCtD
Levobunolol—Pruritus—Erlotinib—kidney cancer	0.0023	0.00232	CcSEcCtD
Levobunolol—Pain—Dactinomycin—kidney cancer	0.00228	0.0023	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—kidney cancer	0.00225	0.00227	CcSEcCtD
Levobunolol—Dizziness—Vinblastine—kidney cancer	0.00224	0.00226	CcSEcCtD
Levobunolol—Dizziness—Everolimus—kidney cancer	0.00223	0.00225	CcSEcCtD
Levobunolol—Diarrhoea—Erlotinib—kidney cancer	0.00223	0.00225	CcSEcCtD
Levobunolol—Hypotension—Vincristine—kidney cancer	0.00223	0.00225	CcSEcCtD
Levobunolol—Bradycardia—Capecitabine—kidney cancer	0.00223	0.00225	CcSEcCtD
Levobunolol—Feeling abnormal—Dactinomycin—kidney cancer	0.0022	0.00222	CcSEcCtD
Levobunolol—Hypersensitivity—Sorafenib—kidney cancer	0.00216	0.00218	CcSEcCtD
Levobunolol—Dizziness—Erlotinib—kidney cancer	0.00215	0.00217	CcSEcCtD
Levobunolol—Paraesthesia—Vincristine—kidney cancer	0.00214	0.00216	CcSEcCtD
Levobunolol—Headache—Vinblastine—kidney cancer	0.00212	0.00214	CcSEcCtD
Levobunolol—Headache—Everolimus—kidney cancer	0.00211	0.00213	CcSEcCtD
Levobunolol—Hypotension—Gemcitabine—kidney cancer	0.00211	0.00213	CcSEcCtD
Levobunolol—Visual impairment—Capecitabine—kidney cancer	0.00211	0.00213	CcSEcCtD
Levobunolol—Asthenia—Sorafenib—kidney cancer	0.0021	0.00212	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—kidney cancer	0.00209	0.00211	CcSEcCtD
Levobunolol—Syncope—Paclitaxel—kidney cancer	0.00208	0.0021	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—kidney cancer	0.00208	0.0021	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—kidney cancer	0.00208	0.0021	CcSEcCtD
Levobunolol—Hypersensitivity—Sunitinib—kidney cancer	0.00208	0.00209	CcSEcCtD
Levobunolol—Pruritus—Sorafenib—kidney cancer	0.00207	0.00209	CcSEcCtD
Levobunolol—Erythema multiforme—Capecitabine—kidney cancer	0.00207	0.00209	CcSEcCtD
Levobunolol—Palpitations—Paclitaxel—kidney cancer	0.00205	0.00207	CcSEcCtD
Levobunolol—Headache—Erlotinib—kidney cancer	0.00204	0.00206	CcSEcCtD
Levobunolol—Loss of consciousness—Paclitaxel—kidney cancer	0.00204	0.00206	CcSEcCtD
Levobunolol—Pain—Vincristine—kidney cancer	0.00204	0.00206	CcSEcCtD
Levobunolol—Diplopia—Doxorubicin—kidney cancer	0.00204	0.00206	CcSEcCtD
Levobunolol—Paraesthesia—Gemcitabine—kidney cancer	0.00203	0.00205	CcSEcCtD
Levobunolol—Asthenia—Sunitinib—kidney cancer	0.00202	0.00204	CcSEcCtD
Levobunolol—Dyspnoea—Gemcitabine—kidney cancer	0.00202	0.00203	CcSEcCtD
Levobunolol—Nausea—Vinblastine—kidney cancer	0.00201	0.00203	CcSEcCtD
Levobunolol—Nausea—Everolimus—kidney cancer	0.002	0.00202	CcSEcCtD
Levobunolol—Diarrhoea—Sorafenib—kidney cancer	0.002	0.00202	CcSEcCtD
Levobunolol—Pruritus—Sunitinib—kidney cancer	0.00199	0.00201	CcSEcCtD
Levobunolol—Chest pain—Paclitaxel—kidney cancer	0.00198	0.00199	CcSEcCtD
Levobunolol—Hypersensitivity—Dactinomycin—kidney cancer	0.00197	0.00198	CcSEcCtD
Levobunolol—Arrhythmia—Capecitabine—kidney cancer	0.00195	0.00197	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—kidney cancer	0.00194	0.00195	CcSEcCtD
Levobunolol—Dizziness—Sorafenib—kidney cancer	0.00194	0.00195	CcSEcCtD
Levobunolol—Pain—Gemcitabine—kidney cancer	0.00193	0.00195	CcSEcCtD
Levobunolol—Nausea—Erlotinib—kidney cancer	0.00193	0.00195	CcSEcCtD
Levobunolol—Alopecia—Capecitabine—kidney cancer	0.00193	0.00195	CcSEcCtD
Levobunolol—Diarrhoea—Sunitinib—kidney cancer	0.00193	0.00194	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—kidney cancer	0.00192	0.00193	CcSEcCtD
Levobunolol—Asthenia—Dactinomycin—kidney cancer	0.00191	0.00193	CcSEcCtD
Levobunolol—Confusional state—Paclitaxel—kidney cancer	0.00191	0.00193	CcSEcCtD
Levobunolol—Dizziness—Sunitinib—kidney cancer	0.00186	0.00188	CcSEcCtD
Levobunolol—Feeling abnormal—Gemcitabine—kidney cancer	0.00186	0.00188	CcSEcCtD
Levobunolol—Shock—Paclitaxel—kidney cancer	0.00186	0.00188	CcSEcCtD
Levobunolol—Headache—Sorafenib—kidney cancer	0.00184	0.00185	CcSEcCtD
Levobunolol—Diarrhoea—Dactinomycin—kidney cancer	0.00183	0.00184	CcSEcCtD
Levobunolol—Hypotension—Paclitaxel—kidney cancer	0.00177	0.00178	CcSEcCtD
Levobunolol—Headache—Sunitinib—kidney cancer	0.00177	0.00178	CcSEcCtD
Levobunolol—Hypersensitivity—Vincristine—kidney cancer	0.00176	0.00177	CcSEcCtD
Levobunolol—Nausea—Sorafenib—kidney cancer	0.00174	0.00175	CcSEcCtD
Levobunolol—Asthenia—Vincristine—kidney cancer	0.00171	0.00173	CcSEcCtD
Levobunolol—Syncope—Capecitabine—kidney cancer	0.00171	0.00172	CcSEcCtD
Levobunolol—Paraesthesia—Paclitaxel—kidney cancer	0.0017	0.00171	CcSEcCtD
Levobunolol—Dyspnoea—Paclitaxel—kidney cancer	0.00169	0.0017	CcSEcCtD
Levobunolol—Palpitations—Capecitabine—kidney cancer	0.00168	0.0017	CcSEcCtD
Levobunolol—Nausea—Sunitinib—kidney cancer	0.00167	0.00169	CcSEcCtD
Levobunolol—Loss of consciousness—Capecitabine—kidney cancer	0.00167	0.00169	CcSEcCtD
Levobunolol—Propranolol—CYP1A1—kidney cancer	0.00163	0.199	CrCbGaD
Levobunolol—Diarrhoea—Vincristine—kidney cancer	0.00163	0.00165	CcSEcCtD
Levobunolol—Asthenia—Gemcitabine—kidney cancer	0.00162	0.00164	CcSEcCtD
Levobunolol—Chest pain—Capecitabine—kidney cancer	0.00162	0.00163	CcSEcCtD
Levobunolol—Pain—Paclitaxel—kidney cancer	0.00162	0.00163	CcSEcCtD
Levobunolol—Pruritus—Gemcitabine—kidney cancer	0.0016	0.00161	CcSEcCtD
Levobunolol—Nausea—Dactinomycin—kidney cancer	0.00159	0.0016	CcSEcCtD
Levobunolol—Dizziness—Vincristine—kidney cancer	0.00158	0.00159	CcSEcCtD
Levobunolol—Confusional state—Capecitabine—kidney cancer	0.00157	0.00158	CcSEcCtD
Levobunolol—Feeling abnormal—Paclitaxel—kidney cancer	0.00156	0.00157	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00156	0.00157	CcSEcCtD
Levobunolol—Diarrhoea—Gemcitabine—kidney cancer	0.00155	0.00156	CcSEcCtD
Levobunolol—Shock—Capecitabine—kidney cancer	0.00153	0.00154	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—kidney cancer	0.00153	0.00154	CcSEcCtD
Levobunolol—Urticaria—Paclitaxel—kidney cancer	0.0015	0.00152	CcSEcCtD
Levobunolol—Headache—Vincristine—kidney cancer	0.00149	0.00151	CcSEcCtD
Levobunolol—Hypotension—Capecitabine—kidney cancer	0.00145	0.00146	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—kidney cancer	0.00144	0.00145	CcSEcCtD
Levobunolol—Headache—Gemcitabine—kidney cancer	0.00142	0.00143	CcSEcCtD
Levobunolol—Nausea—Vincristine—kidney cancer	0.00142	0.00143	CcSEcCtD
Levobunolol—Paraesthesia—Capecitabine—kidney cancer	0.0014	0.00141	CcSEcCtD
Levobunolol—Hypersensitivity—Paclitaxel—kidney cancer	0.0014	0.00141	CcSEcCtD
Levobunolol—Dyspnoea—Capecitabine—kidney cancer	0.00139	0.0014	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—kidney cancer	0.00136	0.00137	CcSEcCtD
Levobunolol—Asthenia—Paclitaxel—kidney cancer	0.00136	0.00137	CcSEcCtD
Levobunolol—Nausea—Gemcitabine—kidney cancer	0.00134	0.00135	CcSEcCtD
Levobunolol—Pruritus—Paclitaxel—kidney cancer	0.00134	0.00135	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—kidney cancer	0.00133	0.00134	CcSEcCtD
Levobunolol—Pain—Capecitabine—kidney cancer	0.00133	0.00134	CcSEcCtD
Levobunolol—Diarrhoea—Paclitaxel—kidney cancer	0.0013	0.00131	CcSEcCtD
Levobunolol—Feeling abnormal—Capecitabine—kidney cancer	0.00128	0.00129	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—kidney cancer	0.00126	0.00127	CcSEcCtD
Levobunolol—Dizziness—Paclitaxel—kidney cancer	0.00125	0.00126	CcSEcCtD
Levobunolol—Alopecia—Doxorubicin—kidney cancer	0.00125	0.00126	CcSEcCtD
Levobunolol—Urticaria—Capecitabine—kidney cancer	0.00123	0.00124	CcSEcCtD
Levobunolol—Headache—Paclitaxel—kidney cancer	0.00119	0.0012	CcSEcCtD
Levobunolol—Hypersensitivity—Capecitabine—kidney cancer	0.00115	0.00115	CcSEcCtD
Levobunolol—Nausea—Paclitaxel—kidney cancer	0.00112	0.00113	CcSEcCtD
Levobunolol—Asthenia—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—kidney cancer	0.0011	0.00111	CcSEcCtD
Levobunolol—Pruritus—Capecitabine—kidney cancer	0.0011	0.00111	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—kidney cancer	0.00108	0.00109	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—kidney cancer	0.00108	0.00109	CcSEcCtD
Levobunolol—Diarrhoea—Capecitabine—kidney cancer	0.00106	0.00107	CcSEcCtD
Levobunolol—Chest pain—Doxorubicin—kidney cancer	0.00105	0.00105	CcSEcCtD
Levobunolol—Dizziness—Capecitabine—kidney cancer	0.00103	0.00104	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—kidney cancer	0.00101	0.00102	CcSEcCtD
Levobunolol—Shock—Doxorubicin—kidney cancer	0.000986	0.000994	CcSEcCtD
Levobunolol—Headache—Capecitabine—kidney cancer	0.000974	0.000982	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—kidney cancer	0.000936	0.000944	CcSEcCtD
Levobunolol—Nausea—Capecitabine—kidney cancer	0.000923	0.000931	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—kidney cancer	0.0009	0.000907	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—kidney cancer	0.000893	0.000901	CcSEcCtD
Levobunolol—Propranolol—ABCB1—kidney cancer	0.000869	0.106	CrCbGaD
Levobunolol—Pain—Doxorubicin—kidney cancer	0.000857	0.000864	CcSEcCtD
Levobunolol—Feeling abnormal—Doxorubicin—kidney cancer	0.000826	0.000832	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—kidney cancer	0.000796	0.000803	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—kidney cancer	0.000738	0.000744	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—kidney cancer	0.000719	0.000725	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—kidney cancer	0.000709	0.000715	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—kidney cancer	0.000686	0.000691	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—kidney cancer	0.000663	0.000668	CcSEcCtD
Levobunolol—Headache—Doxorubicin—kidney cancer	0.000628	0.000633	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—kidney cancer	0.000595	0.0006	CcSEcCtD
